Thursday, October 1, 2009
Ronald P. DeMatteo has been designated the incumbent of the newly endowed Leslie H. Blumgart Chair in Surgery.
Dr. DeMatteo is Vice Chair of the Department of Surgery, Head of the Division of General Surgical Oncology, and Director of the fellowship training program in general surgical oncology. He is a board-certified surgeon with expertise in treating cancers of the liver and pancreas and managing complex hepatobiliary disease. Dr. DeMatteo led two national clinical trials that proved that adjuvant imatinib (Gleevec®) prolongs recurrence-free survival after resection of primary gastrointestinal stromal tumors (GISTs). The findings resulted in approval by the US Food and Drug Administration of adjuvant imatinib. In the laboratory, his research centers on liver and tumor immunology. Dr. DeMatteo received his MD degree in 1990 from Cornell University Medical College. He came to Memorial Sloan Kettering’s in 1997 as a fellow and joined the faculty of the Hepatobiliary Service in 1999.
The Leslie H. Blumgart Chair in Surgery honors the former Chief of Memorial Sloan Kettering’s Hepatobiliary Service for his accomplishments in the treatment of hepatobiliary disease and his work as a distinguished medical leader. Dr. Blumgart has trained most of the leading hepatobiliary surgeons in this country. The chair was endowed with gifts from more than 100 donors, including former patients and trainees, to support a surgeon whose work embodies the high standards and level of commitment that continue to be exemplified by Dr. Blumgart.